These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27672031)

  • 1. Updates on Endothelial Functions of Proangiogenic Prokineticin.
    Nebigil CG
    Hypertension; 2016 Nov; 68(5):1091-1097. PubMed ID: 27672031
    [No Abstract]   [Full Text] [Related]  

  • 2. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
    Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
    FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prokineticin receptors in cardiovascular function: foe or friend?
    Nebigil CG
    Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage].
    Donate-Correa J; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    Med Clin (Barc); 2013 May; 140(9):420-3. PubMed ID: 23337450
    [No Abstract]   [Full Text] [Related]  

  • 6. The vascular actions of relaxin.
    Jeyabalan A; Shroff SG; Novak J; Conrad KP
    Adv Exp Med Biol; 2007; 612():65-87. PubMed ID: 18161482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders.
    Boulberdaa M; Turkeri G; Urayama K; Dormishian M; Szatkowski C; Zimmer L; Messaddeq N; Laugel V; Dollé P; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):842-50. PubMed ID: 21273561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
    Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
    Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-adrenergic activation upregulates expression of relaxin receptor RXFP1 in cardiomyocytes.
    Moore XL; Hong A; Du XJ
    Ann N Y Acad Sci; 2009 Apr; 1160():285-6. PubMed ID: 19416204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation.
    Urayama K; Guilini C; Turkeri G; Takir S; Kurose H; Messaddeq N; Dierich A; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):841-9. PubMed ID: 18421008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxygen radicals in cardiovascular-renal disease.
    Schnackenberg CG
    Curr Opin Pharmacol; 2002 Apr; 2(2):121-5. PubMed ID: 11950621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current world literature.
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):127-34. PubMed ID: 23207725
    [No Abstract]   [Full Text] [Related]  

  • 13. The Role of GPR15 Function in Blood and Vasculature.
    Bauer M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role of relaxin in renal and cardiovascular function.
    Conrad KP; Novak J
    Am J Physiol Regul Integr Comp Physiol; 2004 Aug; 287(2):R250-61. PubMed ID: 15271674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of urotensin-II in cardiovascular disease.
    Russell FD
    Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.
    Gilbert RE; Douglas SA; Krum H
    Curr Opin Investig Drugs; 2004 Mar; 5(3):276-82. PubMed ID: 15083593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxygen radicals and hypertension].
    Manso C
    Rev Port Cardiol; 1989 Jan; 8(1):53-9. PubMed ID: 2517218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired vascular responses to relaxin in diet-induced overweight female rats.
    van Drongelen J; van Koppen A; Pertijs J; Gooi JH; Parry LJ; Sweep FC; Lotgering FK; Smits P; Spaanderman ME
    J Appl Physiol (1985); 2012 Mar; 112(6):962-9. PubMed ID: 22174401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system.
    Chen HH; Burnett JC
    J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S22-8. PubMed ID: 9883743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor in cardiovascular pathophysiology.
    Montrucchio G; Alloatti G; Camussi G
    Physiol Rev; 2000 Oct; 80(4):1669-99. PubMed ID: 11015622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.